O'Connor Stuart Aj, Maese Samuel J, Vizcaychipi Marcela P
Magill Department of Anaesthetics, Chelsea and Westminster Hospital, 369 Fulham Rd., Chelsea, London, SW10 9NH, UK.
J Anaesthesiol Clin Pharmacol. 2023 Apr-Jun;39(2):302-308. doi: 10.4103/joacp.joacp_478_21. Epub 2022 Nov 24.
There is significant interindividual variation in the dose of propofol required for anesthetic induction. Factors dictating this are poorly described, but understanding them would be useful for anesthetic drug dosing. It has been shown in rats and recently in humans that caffeine administration accelerates recovery from anesthesia, but no study has assessed the effect on anesthetic induction.
Forty American Society of Anesthesiologists (ASA)-I, 18-65-year-old patients, undergoing day case general anesthesia with propofol and fentanyl took part in this observational study. Total daily caffeine intake (mg) was estimated using the caffeine assessment tool and caffeine content values from the US Department of Agriculture National Nutrient Database. Pharmacokinetic-pharmacodynamic modeling was used to estimate the effect site concentration of propofol at loss of consciousness (Ce(p) LOC).
Median (interquartile range [IQR]) daily caffeine intake was 106 (51-193) mg. Ce(p) LOC was lower in those with caffeine intake greater than or equal to the median of 106 mg (median (IQR) = 0.64 μg/ml (0.51-0.72) vs. 0.70 μg/ml (0.57-1.10), = 0.04). The effect was robust when controlling for weight-adjusted fentanyl dose, age, smoking status, and alcohol intake (F (1,34) = 4.66, = 0.04).
High daily caffeine intake is associated with lower propofol requirements for day case anesthetic induction. We propose that high daily caffeine intake may cause lower arousal levels prior to surgery due to a relative caffeine deficit caused by being nil by mouth. As such, assessment of daily caffeine intake preoperatively may aid anesthetic drug dosing.
麻醉诱导所需丙泊酚剂量存在显著个体差异。决定这种差异的因素描述甚少,但了解这些因素对麻醉药物剂量设定会有所帮助。在大鼠及最近在人体研究中均已表明,给予咖啡因可加速麻醉苏醒,但尚无研究评估其对麻醉诱导的影响。
40例美国麻醉医师协会(ASA)-I级、年龄在18至65岁之间、接受丙泊酚和芬太尼日间手术全身麻醉的患者参与了本观察性研究。使用咖啡因评估工具及美国农业部国家营养数据库中的咖啡因含量值估算每日咖啡因总摄入量(毫克)。采用药代动力学-药效学模型估算意识消失时丙泊酚的效应室浓度(Ce(p) LOC)。
每日咖啡因摄入量中位数(四分位数间距[IQR])为106(51 - 193)毫克。咖啡因摄入量大于或等于中位数106毫克的患者,其Ce(p) LOC较低(中位数(IQR)= 0.64微克/毫升(0.51 - 0.72),而另一组为0.70微克/毫升(0.57 - 1.10),P = 0.04)。在控制体重调整后的芬太尼剂量、年龄、吸烟状况和酒精摄入量时,该效应依然显著(F(1,34) = 4.66,P = 0.04)。
每日高咖啡因摄入量与日间手术麻醉诱导时较低的丙泊酚需求量相关。我们认为,每日高咖啡因摄入量可能因术前禁食导致相对咖啡因缺乏,从而使术前觉醒水平降低。因此,术前评估每日咖啡因摄入量可能有助于麻醉药物剂量设定。